| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 188.303 | 183.287 | 165.817 | 145.388 | 157.752 | 194.209 | 189.864 | 210.731 | 221.956 | 275.055 |
| Total Income - EUR | 188.306 | 184.444 | 166.198 | 150.453 | 157.752 | 194.209 | 190.034 | 210.731 | 221.956 | 275.055 |
| Total Expenses - EUR | 175.552 | 181.907 | 162.849 | 148.320 | 152.225 | 176.578 | 177.470 | 198.263 | 212.889 | 261.125 |
| Gross Profit/Loss - EUR | 12.754 | 2.537 | 3.348 | 2.133 | 5.526 | 17.631 | 12.564 | 12.468 | 9.067 | 13.930 |
| Net Profit/Loss - EUR | 10.140 | 1.199 | 1.633 | 624 | 3.940 | 15.983 | 10.656 | 10.461 | 7.111 | 11.803 |
| Employees | 4 | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Vali-Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 39.259 | 44.104 | 59.159 | 54.194 | 50.628 | 51.248 | 54.150 | 53.411 | 47.731 | 50.707 |
| Current Assets | 93.036 | 75.573 | 80.016 | 92.701 | 98.842 | 101.081 | 114.148 | 109.532 | 125.305 | 132.150 |
| Inventories | 53.254 | 44.231 | 48.403 | 53.731 | 71.531 | 72.798 | 65.749 | 69.084 | 76.382 | 95.505 |
| Receivables | 25.197 | 10.688 | 26.995 | 38.589 | 23.825 | 15.196 | 30.666 | 35.096 | 47.664 | 35.479 |
| Cash | 14.585 | 20.654 | 4.618 | 381 | 3.486 | 13.088 | 17.733 | 5.351 | 1.259 | 1.166 |
| Shareholders Funds | 76.729 | 77.146 | 76.652 | 75.869 | 78.340 | 92.837 | 101.434 | 90.919 | 97.754 | 109.012 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 55.566 | 42.531 | 62.523 | 71.025 | 71.131 | 59.493 | 66.864 | 72.024 | 75.282 | 73.846 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Vali-Pharm Srl